These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8605634

  • 1. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
    Can J Cardiol; 1996 Feb; 12(2):127-37. PubMed ID: 8605634
    [Abstract] [Full Text] [Related]

  • 2. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E, HOPE Investigators.
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK, Mitchell LB, Pogue J, Bosch J, Dagenais G, Yusuf S, HOPE Investigators.
    Circulation; 2004 Sep 14; 110(11):1413-7. PubMed ID: 15353497
    [Abstract] [Full Text] [Related]

  • 9. Future perspectives and implications.
    Sleight P.
    Int J Clin Pract Suppl; 2001 Jan 14; (117):22-3. PubMed ID: 11715355
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S, HOPE/HOPE-TOO Study Investigators.
    Circulation; 2005 Aug 30; 112(9):1339-46. PubMed ID: 16129815
    [Abstract] [Full Text] [Related]

  • 12. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S, HOPE Study Investigators.
    Circulation; 2006 Jul 18; 114(3):201-8. PubMed ID: 16831981
    [Abstract] [Full Text] [Related]

  • 13. [The HOPE Study. What does it contribute to general practice?].
    Mann J, Sleight P.
    MMW Fortschr Med; 2000 Nov 23; 142(47):28-32. PubMed ID: 11143776
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.
    Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais G, Yusuf S, Lonn E.
    Eur Heart J; 2007 Jun 23; 28(11):1382-8. PubMed ID: 17395677
    [Abstract] [Full Text] [Related]

  • 16. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P, PHARAO Study Group.
    J Hypertens; 2008 Jul 23; 26(7):1487-96. PubMed ID: 18551027
    [Abstract] [Full Text] [Related]

  • 17. What is the relevance of the HOPE study in general practice?
    Kennedy J, Mogensen CE, Ball SG, Castaigne AD, Commerford PJ, Distiller L, Fisher BM, Gonzalez-Jaunatey J, Nosadini R, Novials A, Ostergren J, Palma-Gámiz J, Perrone-Filardi P, Schipperheijn JJ, Senges J, Trevisan R.
    Int J Clin Pract; 2001 Sep 23; 55(7):449-57. PubMed ID: 11594254
    [Abstract] [Full Text] [Related]

  • 18. Ramipril.
    Smith WH, Ball SG.
    Int J Clin Pract; 2000 May 23; 54(4):255-60. PubMed ID: 10912316
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ.
    Med Sci Monit; 2004 Dec 23; 10(12):SR23-8. PubMed ID: 15567997
    [Abstract] [Full Text] [Related]

  • 20. [Cost-effectiveness analysis of Ramipril treatment of patients at high-risk of cardiovascular events in Spain].
    Hart WM, Rubio-Terrés C, Margalet Fernández I, González Juanatey JR.
    An Med Interna; 2002 Oct 23; 19(10):515-20. PubMed ID: 12481494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.